There is no FDA-approved tirzepatide pill. Mounjaro and Zepbound are the only FDA-approved tirzepatide products, and both are weekly injections. Oral tirzepatide at Telos Rx is a compounded needle-free format that is not FDA-approved.
Search "tirzepatide pill" and you get a wall of results that appear to contradict each other. Some pages say the pill does not exist. Others sell one. A third group is talking about a completely different drug without ever saying so.
All of them can be right at once, because "oral tirzepatide" is used for at least three unrelated things.
The Short Version
Tirzepatide is a dual GIP and GLP-1 receptor agonist made by Eli Lilly. It is sold under two brand names, Mounjaro (approved 2022 for type 2 diabetes) and Zepbound (approved November 2023 for chronic weight management, with an added indication in December 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity). Same molecule, two labels.
Both labels describe the same delivery route. The Mounjaro label reads "injection, for subcutaneous use", and the Zepbound label says the same. Neither has a tablet, capsule, or oral presentation of any kind. There is no Mounjaro pill form and no Zepbound tablet.
What the "Tirzepatide Pill" You Saw Probably Was
| What you saw | What it actually is | Molecule | FDA-approved |
|---|---|---|---|
| "Mounjaro pill" or "Zepbound tablet" | No such product exists. Both brands are weekly subcutaneous injections. | Tirzepatide | Injections yes. Pill no. |
| Foundayo (orforglipron) | A genuine once-daily GLP-1 tablet, and the source of most pill confusion. | Orforglipron. Not tirzepatide. | Yes, initial US approval 2026 |
| Rybelsus | An oral tablet for type 2 diabetes, often mislabeled in listicles as a tirzepatide pill. | Semaglutide. Not tirzepatide. | Yes |
| Compounded oral or sublingual tirzepatide | A prescription preparation from a licensed US compounding pharmacy, taken daily under the tongue. | Tirzepatide | No. Compounded medications are not FDA-approved. |
| "Tirzepatide tablets" sold with no prescription | Not a pharmacy product. Tirzepatide in any legitimate form requires a prescription. | Unverified | No |
The Pill That Does Exist Is a Different Drug
Foundayo is the brand name for orforglipron, an Eli Lilly product with an initial US approval in 2026 for chronic weight management alongside a reduced-calorie diet and increased physical activity. It is a real, FDA-approved oral GLP-1 tablet. It is also not tirzepatide, and the two are not interchangeable.
The Foundayo label describes a small-molecule GLP-1 receptor agonist taken once daily, with or without food. Tirzepatide activates two receptors, GIP and GLP-1. Orforglipron activates one. Different molecule, different receptor coverage, different trial program.
One trap worth naming: Foundayo tablets come in strengths of 0.8, 2.5, 5.5, 9, 14.5, and 17.2 mg, and tirzepatide's label titration starts at 2.5 mg weekly. Those numbers are identical and mean nothing to each other.
Why Tirzepatide Was Never Made Into a Swallowed Tablet
This is chemistry, not commercial strategy. Tirzepatide is a peptide with a molecular weight of 4813.53 daltons according to its label. That is a large, protein-like molecule.
Swallow something that size and it meets stomach acid, enzymes evolved specifically to break peptides apart, and an intestinal wall built to keep molecules that big out. Very little survives intact.
Orforglipron sidesteps the problem by not being a peptide at all. It was designed from the start as a small molecule that survives digestion, which is exactly why it can be a plain tablet with no food restrictions. Semaglutide reached tablet form by a third route, pairing the peptide with an absorption enhancer, which is covered in our guide to the semaglutide pill.
No manufacturer has taken a tirzepatide tablet through FDA review. That is why the approved product is still a weekly injection.
So What Is Compounded Oral Tirzepatide?
It is real tirzepatide, prepared by a licensed US compounding pharmacy in a format you do not inject, and dispensed only against a prescription written for an individual patient. Compounded medications are not FDA-approved.
The reason it works as a non-injected format is the route. Oral tirzepatide at Telos Rx is a daily dose held under the tongue for 60 to 90 seconds and then swallowed, so part of the dose absorbs through the tissue under the tongue instead of passing through the stomach first. That is why the terms "oral tirzepatide" and sublingual tirzepatide usually describe the same thing rather than two competing products. The Telos Rx preparation is also compounded with ondansetron, an anti-nausea medication.
It is dosed daily rather than weekly, a deliberate choice for a route that delivers less per administration than an injection.
If needles are the reason you have not started, the needle-free format is worth looking at properly rather than through a search results page. Every request is reviewed by a licensed provider, and approval is not guaranteed.
See oral tirzepatide at Telos RxHow Absorption Differs From the Injection
Here is the part most pages skip. The injection has a published pharmacokinetic profile because it went through FDA review: a documented starting dose of 2.5 mg weekly, increases in 2.5 mg increments no sooner than every 4 weeks, and a maximum of 15 mg weekly. Those figures are label conditions, not instructions for you.
Compounded oral and sublingual tirzepatide have no equivalent published human pharmacokinetic dataset. That has one practical consequence worth understanding clearly: you cannot read a compounded oral dose in milligrams as equivalent to the same number of milligrams injected. Different route, different absorption, different exposure.
Anyone quoting a specific conversion figure between the formats is stating something the published evidence does not support. Format changes go through your prescribing provider, not through arithmetic.
For the broader oral versus injectable picture across the GLP-1 class, our oral vs injectable GLP-1 comparison covers the evidence in more depth.
Choosing Between the Formats
- The injection is the only tirzepatide route with FDA-approved products behind it and the full trial evidence base, including SURMOUNT-1 and SURMOUNT-OSA. Compounded weekly injectable tirzepatide at Telos Rx is listed as low as $139 per month as of publication.
- The oral or sublingual format removes the needle and replaces a weekly step with a daily one. Compounded oral tirzepatide at Telos Rx is listed as low as $129 per month as of publication.
- Both compounded formats are not FDA-approved, both require a prescription, and both carry the same molecule-level cautions, including the boxed warning for thyroid C-cell tumors seen in rodents and a contraindication with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Neither is suitable in pregnancy, and gastrointestinal effects such as nausea, vomiting, diarrhea, and constipation are the most commonly reported side effects on both routes.
If you are weighing the practical differences between injection presentations, our guide to pens versus compounded vials is the companion piece.
How Access Works at Telos Rx
Telos Rx is an online-first, asynchronous telehealth service. You complete a written intake covering health history, current medications, and goals. A licensed provider reviews it on their own schedule, often within hours, and responds in writing, with no appointment to book.
Everything is subject to medical approval by a licensed provider, and approval is not guaranteed. If approved, shipping is free and takes 48 hours. Pricing is flat and does not rise as a clinician titrates the dose, FSA and HSA are accepted, and you can cancel at any time.
Keep Reading
- What Is Tirzepatide? The Complete Guide
- Is Mounjaro Tirzepatide? Mounjaro, Zepbound and Compounded
- Tirzepatide Dosage: The Titration Schedule Explained
- Tirzepatide Cost: Compounded vs Mounjaro and Zepbound
- Tirzepatide Side Effects: What the Evidence Shows
- How to Get Tirzepatide Online Safely: A Checklist
Frequently Asked Questions
Is there an FDA-approved tirzepatide pill?
No. Tirzepatide has two FDA-approved products, Mounjaro and Zepbound, and both are weekly subcutaneous injections. Neither label includes a tablet, capsule, or any oral presentation. Compounded oral and sublingual tirzepatide exist as prescription preparations from licensed US compounding pharmacies, but compounded medications are not FDA-approved.
Is there a Mounjaro pill form?
No. Mounjaro is tirzepatide injection for subcutaneous use, and there is no Mounjaro pill or tablet at any strength. Anything advertised as a Mounjaro pill form is either a different drug, a compounded preparation that is not FDA-approved, or an unregulated product being sold without a prescription.
Is Foundayo the same as tirzepatide?
No. Foundayo is the brand name for orforglipron, a small-molecule GLP-1 receptor agonist taken as a once-daily tablet with or without food. Tirzepatide is a peptide that activates two receptors, GIP and GLP-1. They are different molecules with different trial programs, and their milligram strengths are not comparable to each other.
Do tirzepatide tablets work as well as the injection?
The comparison cannot be made from published data. The injection has FDA-reviewed pharmacokinetics and a large trial base. Compounded oral and sublingual tirzepatide have no equivalent published human pharmacokinetic dataset, so an oral dose in milligrams cannot be treated as equivalent to the same number of milligrams injected. Your prescribing provider makes that assessment.
What is sublingual tirzepatide?
It is compounded tirzepatide taken as a daily dose held under the tongue, at Telos Rx for 60 to 90 seconds, and then swallowed. Part of the dose absorbs through the tissue under the tongue rather than passing through the stomach first. In practice, oral tirzepatide and sublingual tirzepatide usually describe the same product. It is not FDA-approved.
Can I buy tirzepatide pills without a prescription?
No legitimate source sells tirzepatide in any format without a prescription. Tirzepatide requires evaluation by a licensed provider before it can be dispensed, whether the format is an injection, an oral dose, or a sublingual dose. Products advertised without a prescription requirement are outside the licensed pharmacy system and should be treated accordingly.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
If the needle was the sticking point, start with the oral tirzepatide page to see the format, the pricing, and what is included, then complete the written intake at start.telosrx.com. A licensed provider reviews every request, and approval is not guaranteed.